Valantine Hannah Insider Trading Activity
Valantine Hannah has been net-selling over the last 12 months with 0 purchases and 8 sales across 2 different companies.
BBIO is the most-traded position with 6 trades. The largest single transaction was a sale of BBIO for $1.7M on Nov 12, 2025.
Performance Scorecard
Forward stock performance after each transaction by Valantine Hannah. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -5.4% | 8% | 12 |
| 90 days | — | -7.6% | 20% | 10 |
| 120 days | — | -13.4% | 10% | 10 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade Markers🔒 Subscribe to see trade entries
Pro members see exactly when Valantine Hannah bought and sold BBIO.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Jul 16, 2026 | CDNA | Sell | 100 | $36.55 | $4K | −0.3% | Director | |
Jul 16, 2026 | CDNA | Sell | 28,679 | $36.14 | $1.0M | −43.8% | Director | |
Jun 23, 2026 | BBIO | Sell | 2,196 | $68.57 | $151K | −19.2% | Director | |
Jun 22, 2026 | BBIO | Sell | 2,808 | $68.00 | $191K | −19.7% | Director | |
Mar 10, 2026 | BBIO | Sell | 8,671 | $72.00 | $624K | −53.7% | Director | |
Feb 27, 2026 | BBIO | Sell | 10,900 | $67.84 | $739K | −59.4% | Director | |
Feb 27, 2026 | BBIO | Sell | 14,584 | $67.08 | $978K | −44.3% | Director | |
Nov 12, 2025 | BBIO | Sell | 25,484 | $66.07 | $1.7M | −77.3% | Director | |
Jun 26, 2025 | BBIO | Sell | 876 | $44.11 | $39K | −8.9% | Director | |
Jun 26, 2025 | BBIO | Sell | 1,542 | $44.01 | $68K | −17.1% | Director | |
Jun 26, 2025 | BBIO | Sell | 398 | $44.13 | $18K | −14.8% | Director | |
Jun 26, 2025 | BBIO | Sell | 1,891 | $44.03 | $83K | −82.6% | Director | |
Jun 18, 2025 Filed 3d late | CDNA | Sell | 10,570 | $19.16 | $203K | −21.3% | Director | |
Jun 10, 2025 | BBIO | Sell | 4,292 | $40.00 | $172K | −70.9% | Director |
Top Companies Traded
Other insiders at BridgeBio Pharma, Inc.
8 other tracked filers at BBIO.